Journal of Neurochemistry

Vascular neuroprotection via TrkB- and Akt-dependent cell survival signaling

Authors

  • Shuzhen Guo,

    Corresponding author
    • Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
    Search for more papers by this author
  • Angel T. Som,

    1. Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
    Search for more papers by this author
  • Christian Waeber,

    1. Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
    Search for more papers by this author
  • Eng H. Lo

    Corresponding author
    • Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
    Search for more papers by this author

Address correspondence and reprint requests to Shuzhen Guo or Eng H. Lo, Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.E-mails: Sguo@partners.org; Lo@helix.mgh.harvard.edu

Abstract

The cerebral endothelium can be a vital source of signaling factors such as brain-derived neurotrophic factor that defends the neuronal parenchyma against stress and injury. But the underlying mechanisms remain to be fully defined. Here, we use cell models to ask how vascular neuroprotection is sustained. Human brain endothelial cells were grown in culture, and conditioned media were transferred to primary rat cortical neurons. Brain endothelial cell-conditioned media activated neuronal Akt signaling and protected neurons against hypoxia and oxygen-glucose deprivation. Blockade of Akt phosphorylation with the PI3-kinase inhibitor LY294002 negated this vascular neuroprotective effect. Upstream of Akt signaling, the brain-derived neurotrophic factor receptor TrkB (neurotrophic tyrosine kinase receptor, type 2) was involved because depletion with TrkB/Fc eliminated the ability of endothelial-conditioned media to protect neurons against hypoxia. Downstream of Akt signaling, activation of GSK-3β (glycogen synthase kinase 3 beta), caspase 9, caspase 3 and Bad pathways were detected. Taken together, these findings suggest that the molecular basis for vascular neuroprotection involves TrkB-Akt signaling that ameliorates neuronal apoptosis. Further investigation of these mechanisms may reveal new approaches for augmenting endogenous vascular neuroprotection in stroke, brain injury, and neurodegeneration.

Abbreviations used
BDNF

brain-derived neurotrophic factor

FBS

fetal bovine serum

HBSS

Hank's Balanced Salt Solution

Cell–cell interactions between neuronal, glial, and vascular compartments form the basis for function and dysfunction in the neurovascular unit (Lo et al. 2003; Guo and Lo 2009). For example, interactions among endothelial cells, astrocytes, and pericytes help sustain the blood–brain barrier (Armulik et al. 2010; Daneman et al. 2010), and disruptions in gliovascular signaling may cause blood–brain barrier leakage in many CNS diseases(Wolburg et al. 2009; Chaitanya et al. 2011). Similarly, signaling between neuronal and vascular cells is also important. Interactions between cerebral endothelium and neuronal precursor cells may involve common mediators termed angioneurins that support angiogenesis and neurogenesis during normal development as well as during recovery after stroke and brain injury (Ohab et al. 2006; Zacchigna et al. 2008).

Although the conceptual basis for these cell–cell interactions in the neurovascular unit is well accepted, the subsequent neuroprotective mechanisms involved remain to be fully elucidated. We and others previously suggested that cerebral endothelium could protect neurons from oxidative stress and various metabolic insults via the secretion of growth factors such as brain-derived neurotrophic factor (BDNF), insulin-like growth factors (IGF1 and IGF2), pleiotrophin, and stromal cell-derived factor-1 (SDF1) (Dugas et al. 2008; Guo et al. 2008). Here, we tested the hypothesis that vascular neuroprotection is subserved by the ability of trophic mediators to activate patterned pathways of PI-3K/Akt survival signaling that block caspase-mediated neuronal death.

Methods and materials

Rat primary neurons culture

Rat primary neurons were cultured from embryonic day 17 cortices, and isolated cells were plated onto poly-d-lysine-coated plates or dishes with medium consisting of NeuroBasal, 2% B27 (Invitrogen, Carlsbad, CA, USA), 03 mM l-glutamine, and 100 units/mL penicillin and streptomycin. Media were half-changed every 3 days, and cells were used at days in vitro (DIV) 7–9. All experiments were performed following Massachusetts General Hospital-approved protocols following NIH Guidelines for Use and Care of Laboratory Animals that include appropriate anesthesia and minimization of animal number usage.

Human brain microvascular endothelial cells

A human brain microvascular endothelial cell line, THBMEC (Callahan et al. 2004) was maintained in complete medium consisting of RPMI1640 medium (Invitrogen), 10% Fetal bovine serum (FBS), 10% NuSerum (BD Bioscience, Franklin Lakes, NJ, USA), 1 mM sodium pyruvate, non-essential amino acids, vitamins in Minimal Essential Medium, and 100 units/mL penicillin and streptomycin. To prepare endothelial-conditioned medium (Guo et al. 2008), the endothelial cells were seeded in human fibronectin (BD Bioscience)-coated 100 mm dishes. After overnight serum starvation, fresh serum-free combination media (RPMI:NeuroBasal = 1 : 1) were added. Endothelial-conditioned media (E-CM) were collected after 24 h incubation and then centrifuged to collect the supernatant, which would be used to neurons for hypoxia treatment.

To confirm the relevance of our findings, key experiments were repeated with primary human brain microvascular endothelial cells (HBMEC, purchased from ScienCell Research Laboratories, Carlsbad, CA, USA). Cells were maintained on human fibronectin-coated dish with endothelial cell medium- basal plus 5% FBS, 1% endothelial cell growth supplement, and 1% penicillin/streptomycin solution. Cells were used at passage 2 to obtain endothelial-conditioned media. Confluent cells were starved with basal medium plus 0.5% FBS, 0.1% endothelial cell growth supplement, and 0.1% antibiotics overnight, then incubated with serum-free combination media (endothelial cell medium-basal: NeuroBasal = 1 : 1) for 24 h and collected as conditioned media.

Hypoxia setting

Hypoxia was induced in a modular chamber (Billups-Rothenberg Inc, Del Mar, CA, USA) flushed with 90% N2, 5% H2, and 5% CO2 for 30 min at 37°C. The chamber was then sealed and kept at 37°C for 20 h for hypoxia. At the end of hypoxia, the cells were removed from the chamber and directly used for preparation of cell lysate, measurement of cell viability, or staining. Cell viability was measured by standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) transformation [neuronal cell death = (100-cell viability)%].

Oxygen-glucose deprivation setting

Neurons were replaced with glucose-free media and transfered to the modular chamber for hypoxia, as described here. The chamber was sealed and placed at 37°C for 2 h of oxygen-glucose deprivation (OGD), then the cells were removed from the chamber and the glucose-free media were changed to either control media or endothelial-conditioned media with or without LY294002. The cells were maintained in the regular incubator for 22 h of reoxygenation, and the cell viability was measured by standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide transformation.

TrkB/Fc depletion procedure

Endothelial-conditioned media were depleted with recombinant human TrkB/Fc chimera (R & D Systems, Minneapolis, MN, USA) to remove BDNF. Briefly, 2 μg/mL TrkB/Fc was added to media for 2 h at 4°C with rotation, and equal amounts of normal human IgG (Zymed Laboratories Inc., South San Francisco, CA, USA) were added as control. Protein A agarose immunoprecipitation reagent was then added for 4 h at 4°C with rotation. The media were centrifuged to discard the agarose pellet, and the depleted supernatant was used for conditioned media experiments.

Immunoblotting

Cells were lysed using lysis buffer (Cell Signaling Technology, Danvers, MA, USA) and centrifuged for supernatant. The protein concentration was determined using Bradford Assay (Bio-Rad Laboratories, Hercules, CA, USA). Total lysate of cells (20 μg per lane) were separated in precast 4–20% gradient Tris-glycine sodium dodecyl sulfate -polyacrylamide gels (Invitrogen), and then transferred to polyvinylidene difluoride membrane (Invitrogen). After blocking with 0.2% TropixI-block (Applied Biosystems, Foster City, CA, USA), membranes were incubated overnight at 4°C with indicated primary antibodies (all from Cell Signaling Technology), and 1 h at 20–25°C with horseradish peroxidase-conjugated secondary antibodies (Amersham Pharmacia Biotech, Piscataway, NJ, USA) The immune complexes were visualized by enhanced chemiluminescent substrate (Pierce, Rockford, IL, USA). All immunoblots were repeated for at least four independent experiments, and the optical densities for each band were analyzed by Image J program (National Institutes of Health, Bethesda, MD, USA), the levels of housekeeping gene β-Actin were used as loading control.

Live/dead cell staining

The LIVE/DEAD Reduced Biohazard Viability/Cytotoxicity kit (Invitrogen) was used to stain the neurons after hypoxia. Living cells with an intact membrane were stained green by SYTO 10, a highly membrane-permeant fluorescent nucleic acid stain, whereas cells with a compromised membrane, considered to be dead or dying, were stained red by DEAD Red (ethidium homodimer-2), a cell-impermeant fluorescent nucleic acid stain. Briefly, the cells were washed once with Hank's Balanced Salt Solution (HBSS) (Invitrogen), and then incubated with both dyes (1 : 500 dilution of each) for 15 min in darkness at 20–25°C. The cells were washed again with HBSS after removing the dye solution and covered with HBSS for observation directly.

Statistical analysis

All the experiments were performed in triplicates, repeated three to five times independently. Quantitative data were expressed as mean + SD and analyzed with anova followed by Tukey Honestly significant difference (HSD) multiple comparisons. Differences of p < 0.05 were considered significant.

Results

PI-3K/Akt activation in neurons protected by endothelial-conditioned media

PI-3K/Akt is a highly conserved pathway for neuroprotection (Sugawara et al. 2004; Zhao et al. 2006) so we assessed this mechanism here. A human brain endothelial cell line was grown in culture then conditioned media was transferred to neurons. Incubation with endothelial-conditioned media rapidly increased phospho-Akt levels in neurons within 30–60 min (Fig. 1a). An important downstream target of Akt is GSK-3β, so phospho-GSK-3β levels were examined. Consistent with activation of Akt signaling, phosho-GSK-3β levels in neurons were also increased by endothelial-conditioned media (Fig. 1a). As expected, endothelial-conditioned media were neuroprotective, decreasing neuronal death after 20-h hypoxia (Fig. 1b). The importance of Akt signaling in this vascular form of neuroprotection was tested pharmacologically. Co-treatment of neurons with the PI-3K inhibitor LY294002, to inhibit Akt phosphorylation, blocked the ability of endothelial-conditioned media to protect neurons against hypoxia (Fig. 1b and c) and oxygen-glucose deprivation (Fig. 1d). To confirm that these results were not solely because of an artifact of the endothelial cell line, experiments were repeated with primary human brain endothelial cells. Similarly, endothelial-conditioned media increased the phosphorylation of Akt and GSK-3β (Fig. 2a), and reduced neuronal cell death after hypoxia (Fig. 2b).

Figure 1.

(a) Phosphorylation of Akt and GSK-3β in neurons was induced by conditioned media from brain cerebral endothelial cells THBMEC, after short incubation times. (b) staining of live (green) and dead (red) neurons after hypoxia, showed that neuronal death was prevented by E-CM and that the PI-3K inhibitor LY294002 blocked the effect of E-CM. Nx for normoxic neurons; Hy for hypoxic neurons; Hy/E-CM for hypoxic neurons exposed to E-CM; Hy/E-CM/LY for hypoxic neurons exposed to E-CM plus LY294002. (c) Quantitative analysis of the effects shown in 1b. *p < 0.05 versus neurons under hypoxia with E-CM. (d) neuronal death after OGD was also prevented by E-CM and LY294002 blocked the effect of E-CM. *p < 0.05 versus neurons under OGD with E-CM.

Figure 2.

(a) Phosphorylation of Akt and GSK-3β in neurons was induced by conditioned media from brain cerebral endothelial cells HBMEC, after short incubation times. (b) co-incubation with the PI-3K inhibitor LY294002 blocked the neuroprotective effect of E-CM from HBMEC. *p < 0.05 versus neurons under hypoxia with E-CM.

Reduction of apoptotic mediators in hypoxic neurons by endothelial-conditioned media

Neuronal death typically involves apoptotic-like mechanisms (Tamatani et al. 1998; Sugawara et al. 2004; Ness et al. 2006) hence we examined this phenomenon in our model system. After 20-h hypoxia, cleaved fragments of caspase 3 and caspase 9 were increased in neurons (Fig. 3a–d), suggesting the activation of these caspases. Neuroprotection with endothelial-conditioned media effectively suppressed the cleaved levels of both caspase 3 and caspase 9 (Fig. 3). Along with caspases, the prototypical apoptotic mediator Bad was also detected. Neuroprotection with endothelial-conditioned media significantly reduced Bad (Fig. 3a and e).

Figure 3.

(a) Immunoblotting showed that the cleavage of caspase 9 and caspase 3 were increased in neurons after hypoxia. These effects of hypoxia, and the level of proapoptotic protein Bad were all decreased in hypoxic neurons exposed to E-CM. (b–e) Optical densitometry was used to quantify each protein, normalized to levels of β–Actin. *p < 0.05 between two groups.

Upstream signaling via TrkB in vascular neuroprotection

We and others previously suggested that BDNF in particular may play a central role for neuroprotective coupling between vascular and neuronal compartments (Dugas et al. 2008; Guo et al. 2008; Navaratna et al. 2011). As expected, BDNF protein was easily detectable in our endothelial-conditioned media. ELISA showed that these cultures of brain microvascular endothelial cells produced and secreted BDNF at a rate of ≈ 50 pg per 106 cells over 24 h. Here, we asked whether the neuroprotective effects on PI-3K/Akt signaling and caspase blockade were related to the BDNF receptor TrkB. Transfer of endothelial-conditioned media to neurons increased phospho-Akt levels in neurons (Fig. 4a, as showed in Fig. 1a), whereas blocking BDNF in the conditioned media with TrkB/Fc depletion reduced phospho-Akt levels (Fig. 4a). Consistent with these upstream effects on Akt signaling, depletion with TrkB/Fc also prevented endothelial-conditioned media from suppressing caspase 3 cleavage and activation (Fig. 4b and c). Furthermore, there was some evidence of feedback. Hypoxia increased TrkB protein levels in neurons (Fig. 4d and e), which was consistent with previous reports (Merlio et al. 1993; Ferrer et al. 2001; Martens et al. 2007) and might be a compensation reaction in injured neurons to activate this endogenous survival signal. Neuroprotection with endothelial-conditioned media appeared to lower TrkB levels, perhaps indicating less reaction with reduced injury (Fig. 4d and e).

Figure 4.

(a) E-CM depleted by TrkB/Fc did not induce the phosphorylation of Akt in neurons after 30 min incubation. (b) incubation with E-CM blocked cleavage of Caspase 3 in neurons after hypoxia, but incubation with E-CM depleted by TrkB/Fc had no effect on increased cleavage of Caspase 3 in neurons after hypoxia. (c) optical densitometry of cleaved Caspase 3, normalized to β–Actin. (d) hypoxia increased TrkB expression in neurons, which was blocked by E-CM. Depleted E-CM had no blocking effect on TrkB expression. (e) optical densitometry of gp 145TrkB, normalized to β–Actin. *p < 0.05 between two groups. (f) proposed mechanisms for neuroprotection by cerebral endothelial cells. Soluble factors from cerebral endothelial cells, such as growth factor brain-derived neurotrophic factor (BDNF), activate PI-3K/Akt survival signaling in neurons through receptors, leading to the activation of GSK-3β, the inhibition of caspases activation and Bad expression, and finally protect the neurons from damage.

Discussion

It is now recognized that blood vessels are not just inert pipes for delivering blood (Ergun et al. 2011; Franses et al. 2011). Instead, the cerebral endothelium comprises a rich source of factors that support neurogenesis, angiogenesis, and endogenous neuroprotection (Leventhal et al. 1999; Shen et al. 2004; Dugas et al. 2008; Guo et al. 2008). In this brief communication, we showed that the ability of cerebral endothelial cells to protect neurons is mediated via upstream TrkB and Akt signaling and downstream caspase suppression (Fig. 4f).

By using a media transfer system, we showed that endothelial-conditioned media up-regulated pro-survival Akt signaling and protected neurons against hypoxic injury. Although admittedly an in vitro approach, this method has been successfully used in the past to dissect cell–cell signaling under various conditions. Endothelial-conditioned media supported growth of subependymal transplants (Leventhal et al. 1999), promoted neurogenesis (Shen et al. 2004), and supported the survival of motoneurons and cortical neurons in culture (Dugas et al. 2008; Guo et al. 2008). Hence, endothelial cells can secrete paracrine factors that affect adjacent neurons. In this study, this neuroprotective coupling seems to involve TrkB and Akt pathways. This idea becomes important in the context of CNS disease, whereby unhealthy endothelium may no longer protect neurons. Loss of vascular neuroprotection has been hypothesized in stroke, brain trauma, and neurodegeneration (Cade 2008; Zacchigna et al. 2008; Guo and Lo 2009).

In our model system, vascular neuroprotection seems to be largely mediated by endothelial-derived BDNF because blockade of the TrkB receptor system interferes with this phenomenon. We (Guo et al. 2008) and others (Leventhal et al. 1999) have suggested that brain endothelial cells express high levels of BDNF. But we cannot exclude the possibility of other neutrophins, such as NT-4 and NT-3, which can also bind to and activate TrkB receptor, might also play some roles. (Schecterson and Bothwell 2010). Furthermore, our cell culture system is based on young cells, so effects of age and different developmental stages may be important in vivo. Ultimately, use of appropriate animal models is warranted, especially with brain endothelial cell specific transgenic animals. The promoter from tyrosine kinase receptor Tie 2 or thyroxine transporter Slco1c1 have been used to create endothelial cell specific or even brain endothelial cell specific transgenic mice (Schlaeger et al. 1997; Ridder et al. 2011). Future studies into vascular neuroprotection using these powerful animal models should be performed.

Taken together, our findings support an endogenous signaling mechanism for vascular neuroprotection. However, several caveats must be kept in mind. First, we focus on cerebral endothelial cells, but other cell types also communicate with neurons. The contributions of astrocytes or pericytes to neuroprotection may be equally important. Second, the experiments here focus on the prevention of caspase-mediated apoptotic-like death. But it is now known that autophagy or even programmed necrosis play key roles in neuronal death (Pandey et al. 2007; Rosenbaum et al. 2010; Wang et al. 2011; Denton et al. 2012). How vascular neuroprotection protects against these other modes of neuron death remains to be determined. Third, although Akt signaling is a prominent pro-survival pathway in neurons, it is possible that other parallel mechanisms may also contribute, for example, extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAP) or JAK-Stat signals (Sugawara et al. 2004; Sun et al. 2008; Colodner and Feany 2010; Karmarkar et al. 2011; Nicolas et al. 2012). How Akt interacts with other pro-survival pathways in vascular neuroprotection warrants further examination. Finally, these data only provide in vitro proof-of-concept in cells. Further in vivo experiments are required to prove that these signals operate in animal models of CNS disease.

Increasingly, the vast network of cerebral endothelium in the brain is no longer viewed only as plumbing. Paracrine and coupling mechanisms between endothelium and the neuronal compartment may be important for homeostasis and defense against CNS injury and disease. Our findings here may support a role of Akt prosurvival signaling and subsequent caspase suppression as relevant mechanisms for vascular neuroprotection.

Acknowledgment

This study is supported in part by National Institutes of Health Grant P01-NS55104, and a Claflin award from Massachusetts General Hospital to S.G.

Author contributions

S.G. and E.H.L. designed the experiments. S.G. and A.T.S performed experiments and data analysis. S.G., C.W., and E.H.L. wrote the article.

The authors declare no conflict of interest.

Ancillary